Pura Vida Investments’s Sanofi SNY Stock Holding History

Pura Vida Investments’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-97,684	Closed	-$3.71M	–	241
2022 Q3	$3.71M	Buy	+97,684	New	+$4.35M	0.21%	104

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pura Vida Investments's SNY Position: Q4 2022 in Review

Pura Vida Investments sold out of Sanofi (SNY) in Q4 2022, closing a stake of 97,684 shares — an estimated $3.71M sold.

Pura Vida Investments first reported a position in SNY in Q3 2022 and held it in 1 quarter. The position peaked at $3.71M in Q3 2022. 644 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Pura Vida Investments reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 97,684 Sanofi shares in Q4 2022, an estimated $3.71M.
Pura Vida Investments first reported a position in Sanofi in Q3 2022 and held it in 1 quarter.
Pura Vida Investments's Sanofi position peaked at $3.71M in Q3 2022.
644 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.